R&D
Sponsored
Exploring the future: Opportunities and challenges in cell a...
Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Part 7
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
R&D
Jennifer Schneider’s insights on immunotherapy at JP Morgan ...
Jonah Comstock caught up with Jennifer Schneider, CEO of Centauri Therapeutics, in San Francisco in January during the JP Morgan Healthcare Conference
Oncology
Life Sciences Industry Report - Part 5
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
Partner Content
Return to Europe for the 2nd IMPACCT Real World Evidence Sum...
The IMPACCT Real World Evidence Summit is back, offering the opportunity to bring together 50+ pharma RWE decision makers to discuss integrated evidence plans, data sharing optimization, infrastruc
R&D
Partner Content
4th Circular & Self-Amplifying RNA Therapeutics Summit
With CSL Seqirus and Arcturus Therapeutics successfully developing the first approved self-amplifying RNA vaccine, the field of next generation RNAs celebrates the potential of circular and self-am
